Rough Draft Atlanta
Study points to copay price as reason people stop taking GLP-1 medication for obesity
A study reveals that high out-of-pocket costs, particularly exceeding $75, significantly drive patient nonadherence to GLP-1 obesity medications, highlighting a need for insurance and policy reform.
Read the original at Rough Draft AtlantaMore audio from Rough Draft Atlanta
-
4mAtlanta Hawks, State Farm Arena and Home Depot announce multi-year partnership
The Atlanta Hawks and The Home Depot have formed a multi-year partnership, featuring arena branding, interactive fan experiences, and community-focused initiatives across the Metro Atlanta area.
-
3mProposed DeKalb County amendment seeks to expand non-discrimination laws
Advocacy organizations are urging DeKalb County residents to support an amendment to the county's non-discrimination ordinance to expand LGBTQ+ protections in housing and private employment before the commission potentially votes on October 20.
-
4mMorgan Falls Dog Park reopens with upgraded amenities and ADA access
Sandy Springs officials celebrated the reopening of the renovated and ADA-accessible Morgan Falls Dog Park on Oct. 14, featuring significant drainage improvements and new amenities.
-
5mAtlanta experts share essential fall skincare tips to combat winter dryness
Atlanta dermatologists and estheticians recommend adjusting skincare routines with heavier moisturizers, shorter showers, and sunscreen to combat skin dryness and barrier damage caused by cold, dry autumn weather.
-
11mGrowth of data centers becomes a defining issue of the midterms, entangling some Georgia candidates
Georgia candidates are facing intense scrutiny as local outrage over data center expansion turns into a major campaign issue ahead of the upcoming November elections.